Browse > Article

IDENTIFICATION OF RECEPTOR ACTIVATOR OF NUCLEAR $FACTOR-{\kappa}B$ LIGAND(RANKL) AND OSTEOPROTEGERIN(OPG) IN ODONTOGENIC KERATOCYST  

Ahn, Dong-Kil (Department of Oral and Maxillofacial Surgery, College of Dentistry, Pusan National University)
Ha, Woo-Hun (Department of Oral and Maxillofacial Surgery, College of Dentistry, Pusan National University)
Kim, Seong-Sik (Department of Orthodontics, College of Dentistry, Pusan National University)
Hwang, Dae-Seok (Department of Oral and Maxillofacial Surgery, College of Dentistry, Pusan National University)
Kim, Yong-Deok (Department of Oral and Maxillofacial Surgery, College of Dentistry, Pusan National University)
Shin, Sang-Hun (Department of Oral and Maxillofacial Surgery, College of Dentistry, Pusan National University)
Kim, Uk-Kyu (Department of Oral and Maxillofacial Surgery, College of Dentistry, Pusan National University)
Kim, Jong-Ryoul (Department of Oral and Maxillofacial Surgery, College of Dentistry, Pusan National University)
Chung, In-Kyo (Department of Oral and Maxillofacial Surgery, College of Dentistry, Pusan National University)
Publication Information
Maxillofacial Plastic and Reconstructive Surgery / v.29, no.1, 2007 , pp. 24-32 More about this Journal
Abstract
The odontogenic keratocyst(OKC) is a common developmental odontogenic cyst and represents approximately 11% of odontogenic cysts. It is decided by microscopic and histopathologic determinant rather than by clinical appearance. In this study, expression of RANKL and OPG in OKC in relation to age and gender of patient and recurrence, location of lesion were examined through immuno- histochemical study. The RANKL and OPG antibody staining were used. The obtained result were as follow. 1. Positive immunoreactivity to RANKL/OPG in all specimens was found. 2. There was no significant difference in immunohistochemical expression of RANKL relating to recurrence, location of OKCs and age, gender of patients. 3. There was no significant difference in immunohistochemical expression of OPG relating to recurrence, location of OKCs and age, gender of patients. From above results, it is suggested that activation of osteoclasts by RANKL is an important mechanism by which OKCs cause bone destruction.
Keywords
OKC; RANKL; OPG;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bataineh AB, al Qudah M : Treatment of mandibular don-togenic keratocysts. Oral Surg Oral Med Oral Pathol Oral Radiol 86 : 42, 1998   DOI   ScienceOn
2 Voorsmit RA, Stoelinga PJ, van Haelst UJ : The management of keratocysts. J Maxillofac Surg 9 : 228, 1981   DOI   ScienceOn
3 Sung-Hoon Chung, Eui-Wung Lee : A clinical and histopathologic study of benign odontogenic tumors. J Kor Oral Maxillofac Surg 17(2) : 83, 1991
4 Yasuda H, Shima N, Nakagawa N et al : Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclasto-genesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95 : 3597, 1998
5 O'Brien EA, Williams JH, Marshall MJ : Osteoprotegerin ligand regulates osteoclast adherence to the bone surface of mouse calvaria. Biochem Biophys Res Commun 274 : 281, 2000   DOI   ScienceOn
6 Guise T.A, Mundy G.R : Cancer and bone. Endocr Rev 19 : 18, 1998   DOI   ScienceOn
7 Yasuda H, Shima N, Nakagawa N et al : Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclasto-genesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95 : 3597, 1998
8 Rani CSS, MacDougall M : Dental cells express factors that regulate bone resorption. Mol Cell Biol Res Comm 3 : 145, 2000   DOI   ScienceOn
9 Hiroyuki K, Kiyoshi O : Expression of PTHrP, ODF/RAN-KL and OCIF/OPG in ameloblastoma. J Oral Pathol Med 33 : 46, 2004   DOI   ScienceOn
10 Horowizt MC, Xi Y, Wilson K et al : Control of osteoclas-togenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev 12 : 9, 2001   DOI   ScienceOn
11 Scharffetter K, Balz-Herrmann C, Lagrange W et al : Proliferation kinetics-study of the growth of keratocysts. Morpho-functional explanation for recurrences. J Craniomaxillofac Surg 17 : 226, 1989   DOI   PUBMED
12 Ahlfors E, Larsson, Sjogren S : The odontogenic keratocyst : a benign cystic tumor? J Oral Maxillofac Surg 42 : 10, 1984   DOI   ScienceOn
13 Anand VK, Arrowod JP, Krolls SO ： Malignant potential of the odontogenic keratocyst. Otolaryngol Head Neck Surg 111 : 124, 1994   DOI   PUBMED
14 Nagai M, Kyakumoto S, Sato N : Cancer cells responsible for humoral hypercalcemia express mRNA encoding a secreted form of ODF/TRANCE that induces osteoclast formation. Biochem Biophys Res Commun 269 : 532, 2000   DOI   ScienceOn
15 Philip Sapp J, Lewis R. Eversole et al : Cyst of the oral resions in Contemporary oral and maxillofacial pathology. St. Louis, Mosby 1997
16 Blum B, Moseley J, Miller L et al : Measurement of bone morphogenetic proteins and other growth factors in dem-ineralized bone matrix. Orthopedics 27 : 1686, 2004
17 Forssel K : The primordial cyst, a clinical and radiographic study. Proc Finn Dent Soc 76 : 129, 1980
18 Zhang J, Dai J, Qi Y et al : Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. J Clin Invest 107 : 1235, 2001   DOI   ScienceOn
19 Li TJ, Browne RM, Prime SS et al : p53 expression in odontogenic keratocyst epithelium. J Oral Pathol Med 25 : 249, 1996   DOI   ScienceOn
20 Croucher PI, Shipman CM, Lippitt J et al : Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma Blood 98 : 3534, 2001   DOI   ScienceOn
21 Wttrant Y, Theoleyre S, Chipoy C et al : RANKL/ RANK/OPG : new therapeutic targets in bone tumors and associated osteolysis. Bioch et Biophys Acta 1704 : 49, 2004
22 Guise TA, Chirgwin JM : Transforming growth factor-beta in osteolytic breast cancer bone metastases. Clin Orthop 415 : S32, 2003   DOI   ScienceOn
23 Tay JYY, Bay BH, Yeo JF et al : Identification of RANKL in osteolytic lesions of the facial skeleton. J Dent Res 83(4) : 349, 2004   DOI   ScienceOn
24 Fuller K, Wong B, Fox S et al : TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 188 : 997, 1998   DOI   ScienceOn
25 Chirgwin J.M, Guise TA : Molecular mechanisms of tumor-bone interactions in osteolytic metastases. Crit. Rev Eukaryot Gene Expr 10 : 59, 2000
26 Hoon Myoung et al : Odontogenic keratocyst : Review of 256 cases for recurrence and clinicopathologic parameters. Oral Surg Oral Med Oral Pathol 91 : 328, 2001   DOI   ScienceOn
27 Simonet WS, Lacey DL, Dunstan CR et al : Osteoprotegerin. a novel secreted protein involved in the regulation of bone densty. Cell 89 : 309, 1997   DOI   ScienceOn
28 Wise GE, Lumpkin SJ, Huang H et al : Osteoprotegerin and osteoclst differentiation factor in tooth eruption. J Dent Res 79 : 1937, 2000   DOI   ScienceOn
29 Tsuda E, Goto M, Michizuki S et al : Isolation of a novel cytokine from human fibroblast that specifically inhibitsos-teoclastogenesis. Biochem Biophys Res Commun 234 : 137, 1997   DOI   ScienceOn
30 Kawamoto S, Ejiri S, Hoshi K et al : Immunolocalization of osteoclast differentiation factor in rat periodontium. Arch Oral Biol 47 : 55, 2002   DOI   ScienceOn
31 Fuller K, Wong B, Fox S et al : TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 188 : 997, 1998   DOI   ScienceOn
32 Grimaud E, Soubigou L, Couillaud S et al : RANKL/OPG ratio in increased in severe osteolysis Am J Pathol 163 : 2021, 2003   DOI   PUBMED   ScienceOn
33 Miyamoto T, Ohneda O, Arai F et al : Bifurcation of osteo-clasts and dendritic cells from common progenitors. Blood 98 : 2544, 2001   DOI   ScienceOn
34 Goltzman D : Osteolysis and cancer. J Clin Invest 107 : 1219, 2001   DOI   ScienceOn
35 Wong BG, Rho J, Arron J et al : TRANCE is a novel lig-and of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 272 : 25190, 1997   DOI   ScienceOn
36 O'Brien EA, Williams JH, Marshall MJ : Osteoprotegerin ligand regulates osteoclast adherence to the bone surface of mouse calvaria. Biochem Biophys Res Commun 274 : 281, 2000   DOI   ScienceOn
37 Neville BW, Damm DD, Allen CM et al: Oral and Maillofacial Pathology. Philadelphia, W.B Saunders. 1995, p.594
38 Lacey DL, Timms E, Tan HL et al : Osteoprotegerin lig-and is a cytokine that regulates osteoclast differentiation and activation. Cell 93 : 165, 1998   DOI   ScienceOn
39 Sang-Kweon Cha, Il-Kyu Kim. Seong-Seob Oh et al : Clinical study of cyst in the jaw. J Kor Oral Maxillofac Surg 27(2) : 167, 2001
40 Lacey DL, Timms E, Tan HL et al : Osteoprotegerin lig-and is a cytokine that regulates osteoclast differentiation and activation. Cell 93 : 165, 1998   DOI   ScienceOn
41 Good CR, O'Keefe RJ, Puzas JE et al : Immuno-histochemical study of RANKL in human osteolytic bone tumors. J Surg Oncol 79 : 174, 2002   DOI   ScienceOn